Targeted disruption of organic cation transporter 3 attenuates the pharmacologic response to metformin
about
MATE2 Expression Is Associated with Cancer Cell Response to MetforminVariants in Pharmacokinetic Transporters and Glycemic Response to Metformin: A Metgen Meta-Analysis.Metformin Is a Substrate and Inhibitor of the Human Thiamine Transporter, THTR-2 (SLC19A3).The effect of dipyridamole on the pharmacokinetics of metformin: a randomized crossover study in healthy volunteers.Renoprotective Effects of Metformin are Independent of Organic Cation Transporters 1 &2 and AMP-activated Protein Kinase in the KidneyThe Liver Circadian Clock Modulates Biochemical and Physiological Responses to Metformin.Metformin Accelerates Glycolytic Lactate Production in Cultured Primary Cerebellar Granule Neurons.The Complexities of Interpreting Reversible Elevated Serum Creatinine Levels in Drug Development: Does a Correlation with Inhibition of Renal Transporters Exist?Environment Dictates Dependence on Mitochondrial Complex I for NAD+ and Aspartate Production and Determines Cancer Cell Sensitivity to Metformin.Prediction and validation of enzyme and transporter off-targets for metformin.The antidiabetic drug metformin decreases mitochondrial respiration and tricarboxylic acid cycle activity in cultured primary rat astrocytes.Allele frequency and genotype distribution of a common variant in the 3´-untranslated region of the SLC22A3 gene in patients with type 2 diabetes: Association with response to metformin.Diabetes medication associates with DNA methylation of metformin transporter genes in the human liver.Metformin as an anti-cancer agent: actions and mechanisms targeting cancer stem cells.Renal Transporter-Mediated Drug-Drug Interactions: Are They Clinically Relevant?Identification of genes directly responding to DLK1 signaling in Callipyge sheep.Genetic Heterogeneity of SLC22 Family of Transporters in Drug Disposition.
P2860
Q28555000-67486F40-3D76-4ADA-98BC-9C4EEFE40474Q33658321-797221A9-19B1-42FB-AFA9-C94245542DAAQ36709745-96BD8C9B-77C7-46A7-924C-2EBECE1C4C90Q36908331-FB425644-2072-4174-8E23-C56EC91F07DCQ37366972-7E5575B6-B3CE-47AF-AEF1-C4C248741008Q38620481-5B8A21DC-6AC4-423F-A002-BCC2F289684EQ38688703-3D68D5A0-9B42-48A5-9A08-DB182EC3E261Q38716267-3EC075B1-1E34-4BC1-A21A-AB859A815664Q38740932-B7CEB56F-4C0E-4FF0-8D37-E9139F62F5C7Q38838317-EC4AD6C1-90DB-4CC2-968E-236919742DF3Q38896048-962F9AB9-29F0-476E-9AEA-80F8F4915126Q40348845-EA660DAD-E55B-4222-9281-CD02E7CFBA5AQ41691573-106A9D36-41F4-4196-8C6A-1A7A24C2EC2AQ50001260-97D1FA5E-26D9-4393-A896-1E33CDD175E4Q51659189-57226D76-DE55-45A5-A4FD-ABAAC340C673Q55018738-B97DEE20-6336-48AF-BCA7-308BA6ABE878Q55514622-96B05DB8-9359-4D84-97CE-09F934F5C796
P2860
Targeted disruption of organic cation transporter 3 attenuates the pharmacologic response to metformin
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Targeted disruption of organic ...... acologic response to metformin
@ast
Targeted disruption of organic ...... acologic response to metformin
@en
type
label
Targeted disruption of organic ...... acologic response to metformin
@ast
Targeted disruption of organic ...... acologic response to metformin
@en
prefLabel
Targeted disruption of organic ...... acologic response to metformin
@ast
Targeted disruption of organic ...... acologic response to metformin
@en
P2093
P2860
P356
P1476
Targeted disruption of organic ...... acologic response to metformin
@en
P2093
Ethan G Geier
Eugene C Chen
Kathleen M Giacomini
Ligong Chen
Sophie L Stocker
Xiaomin Liang
P2860
P356
10.1124/MOL.114.096776
P50
P577
2015-04-28T00:00:00Z